These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1694390)
1. Expression of "myelomonocytic" antigens in mesotheliomas and adenocarcinomas involving the serosal surfaces. Wick MR; Mills SE; Swanson PE Am J Clin Pathol; 1990 Jul; 94(1):18-26. PubMed ID: 1694390 [TBL] [Abstract][Full Text] [Related]
2. Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison. Bollinger DJ; Wick MR; Dehner LP; Mills SE; Swanson PE; Clarke RE Am J Surg Pathol; 1989 Aug; 13(8):659-70. PubMed ID: 2473660 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Ordóñez NG Mod Pathol; 2006 Jan; 19(1):34-48. PubMed ID: 16056246 [TBL] [Abstract][Full Text] [Related]
4. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen. Sheibani K; Battifora H; Burke JS Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases. Otis CN; Carter D; Cole S; Battifora H Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954 [TBL] [Abstract][Full Text] [Related]
6. Malignant epithelioid pleural mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural, and immunohistologic study of 103 cases. Wick MR; Loy T; Mills SE; Legier JF; Manivel JC Hum Pathol; 1990 Jul; 21(7):759-66. PubMed ID: 2193875 [TBL] [Abstract][Full Text] [Related]
7. A comparative immunohistochemical study of peritoneal and ovarian serous tumors, and mesotheliomas. Khoury N; Raju U; Crissman JD; Zarbo RJ; Greenawald KA Hum Pathol; 1990 Aug; 21(8):811-9. PubMed ID: 1696923 [TBL] [Abstract][Full Text] [Related]
8. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Attanoos RL; Goddard H; Gibbs AR Histopathology; 1996 Sep; 29(3):209-15. PubMed ID: 8884348 [TBL] [Abstract][Full Text] [Related]
9. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Ordóñez NG Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877 [TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis between mesotheliomas and metastatic adenocarcinomas using monoclonal antibodies against gastrointestinal carcinoma antigen and stage-specific embryonic antigen. Ernst CS; Atkinson B; Chianese D; Peters J; Perry M; Herlyn M; Koprowski H Appl Pathol; 1986; 4(3):115-24. PubMed ID: 2885017 [TBL] [Abstract][Full Text] [Related]
11. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
16. Monomorphic lymphomas arising in patients with Hodgkin's disease. Correlation of morphologic, immunophenotypic, and molecular genetic findings in 12 cases. Casey TT; Cousar JB; Mangum M; Williams ME; Lee JT; Greer JP; Collins RD Am J Pathol; 1990 Jan; 136(1):81-94. PubMed ID: 2297052 [TBL] [Abstract][Full Text] [Related]
17. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Sheibani K; Battifora H; Burke JS; Rappaport H Am J Surg Pathol; 1986 Apr; 10(4):227-36. PubMed ID: 3085523 [TBL] [Abstract][Full Text] [Related]
18. Melan A (A103) is not a marker of mesothelioma. Ordóñez NG; Shen SS; Zenali M; Deavers MT Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):181-4. PubMed ID: 22820661 [TBL] [Abstract][Full Text] [Related]
19. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Andrici J; Jung J; Sheen A; D'Urso L; Sioson L; Pickett J; Parkhill TR; Verdonk B; Wardell KL; Singh A; Clarkson A; Watson N; Toon CW; Gill AJ Hum Pathol; 2016 May; 51():9-15. PubMed ID: 27067777 [TBL] [Abstract][Full Text] [Related]